Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Scott

Showing results (211-220 of 253) with videos related to

Pageof 26
Sort By:
AIDS Patient Care and Stds|November 1, 2003
Optimizing care for African-American HIV-positive patientsKimberly Y Smith, Andre Brutus, Ronald Cathcart, et al.
The FEBS Journal|January 17, 2020
Proprotein convertase 7 (PCSK7) reduces apoA-V levelsYahya Ashraf, Stéphanie Duval, Vatsal Sachan, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|May 3, 2019
Noninvasive Neurological Monitoring in Extracorporeal Membrane OxygenationSung-Min Cho, Wendy Ziai, Yunis Mayasi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 20, 2006
Azithromycin combination therapy with artesunate or quinine for the treatment of uncomplicated Plasmodium falciparum malaria in adults: a randomized, phase 2 clinical trial in ThailandHarald Noedl, Srivicha Krudsood, Kobsiri Chalermratana, et al.
BMJ Open|November 14, 2019
Relieving acute pain (RAP) study: a proof-of-concept protocol for a randomised, double-blind, placebo-controlled trialLuana Colloca, Se Eun Lee, Meghan Nichole Luhowy, et al.
Circulation|July 26, 2013
AMG145, a monoclonal antibody against proprotein convertase subtilisin kexin type 9, significantly reduces lipoprotein(a) in hypercholesterolemic patients receiving statin therapy: an analysis from the LDL-C Assessment with Proprotein Convertase Subtilisin Kexin Type 9 Monoclonal Antibody Inhibition Combined with Statin Therapy (LAPLACE)-Thrombolysis in Myocardial Infarction (TIMI) 57 trialNihar R Desai, Payal Kohli, Robert P Giugliano, et al.
The Journal of Biological Chemistry|December 22, 2016
The Proprotein Convertase Subtilisin/Kexin Type 9-resistant R410S Low Density Lipoprotein Receptor Mutation: A NOVEL MECHANISM CAUSING FAMILIAL HYPERCHOLESTEROLEMIADelia Susan-Resiga, Emmanuelle Girard, Robert Scott Kiss, et al.
Psychosomatics|August 2, 2018
Electronic Medical Record Reporting Enhances Proactive Psychiatric ConsultationChristine T Finn, Devendra Thakur, Katherine M Shea, et al.
Brain Research. Molecular Brain Research|October 8, 2004
In vitro and in vivo effects of an alpha3 neuronal nicotinic acetylcholine receptor antisense oligonucleotideMonique R Adams, Arthur L Nikkel, Diana L Donnelly-Roberts, et al.
The Journal of Thoracic and Cardiovascular Surgery|March 7, 2006
Guidelines for credentialing of practitioners to perform endovascular stent-grafting of the thoracic aortaNicholas T Kouchoukos, Joseph E Bavaria, Joseph S Coselli, et al.
Pageof 26

Showing results (211-220 of 253) with videos related to

Sort By:
Pageof 26
AIDS Patient Care and Stds|November 1, 2003
Optimizing care for African-American HIV-positive patientsKimberly Y Smith, Andre Brutus, Ronald Cathcart, et al.
The FEBS Journal|January 17, 2020
Proprotein convertase 7 (PCSK7) reduces apoA-V levelsYahya Ashraf, Stéphanie Duval, Vatsal Sachan, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|May 3, 2019
Noninvasive Neurological Monitoring in Extracorporeal Membrane OxygenationSung-Min Cho, Wendy Ziai, Yunis Mayasi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 20, 2006
Azithromycin combination therapy with artesunate or quinine for the treatment of uncomplicated Plasmodium falciparum malaria in adults: a randomized, phase 2 clinical trial in ThailandHarald Noedl, Srivicha Krudsood, Kobsiri Chalermratana, et al.
BMJ Open|November 14, 2019
Relieving acute pain (RAP) study: a proof-of-concept protocol for a randomised, double-blind, placebo-controlled trialLuana Colloca, Se Eun Lee, Meghan Nichole Luhowy, et al.
Circulation|July 26, 2013
AMG145, a monoclonal antibody against proprotein convertase subtilisin kexin type 9, significantly reduces lipoprotein(a) in hypercholesterolemic patients receiving statin therapy: an analysis from the LDL-C Assessment with Proprotein Convertase Subtilisin Kexin Type 9 Monoclonal Antibody Inhibition Combined with Statin Therapy (LAPLACE)-Thrombolysis in Myocardial Infarction (TIMI) 57 trialNihar R Desai, Payal Kohli, Robert P Giugliano, et al.
The Journal of Biological Chemistry|December 22, 2016
The Proprotein Convertase Subtilisin/Kexin Type 9-resistant R410S Low Density Lipoprotein Receptor Mutation: A NOVEL MECHANISM CAUSING FAMILIAL HYPERCHOLESTEROLEMIADelia Susan-Resiga, Emmanuelle Girard, Robert Scott Kiss, et al.
Psychosomatics|August 2, 2018
Electronic Medical Record Reporting Enhances Proactive Psychiatric ConsultationChristine T Finn, Devendra Thakur, Katherine M Shea, et al.
Brain Research. Molecular Brain Research|October 8, 2004
In vitro and in vivo effects of an alpha3 neuronal nicotinic acetylcholine receptor antisense oligonucleotideMonique R Adams, Arthur L Nikkel, Diana L Donnelly-Roberts, et al.
The Journal of Thoracic and Cardiovascular Surgery|March 7, 2006
Guidelines for credentialing of practitioners to perform endovascular stent-grafting of the thoracic aortaNicholas T Kouchoukos, Joseph E Bavaria, Joseph S Coselli, et al.
Pageof 26